German biosimilars company Formycon has announced that its 2025/2029 corporate bond was significantly oversubscribed due to ...

US biotech major Biogen today announced new data that reinforce the clinical impact of nusinersen across a broad spectrum of ...

Despite calls for the meeting to be delayed, Wednesday’s meeting of the Centers for Disease Control and Prevention's (CDC's) Advisory Committee on Immunization Practices (ACIP) went ahead.

In a significant showcase for investors, BeOne Medicines announced major advancements to its industry-leading oncology ...

Italian drugmaker Philogen has announced its decision to voluntarily withdraw the application for marketing authorization to ...

Indian drugmaker Biocon has announced that Health Canada has granted a Notice of Compliance for Yesafili (aflibercept), a ...

Japanese drugmaker Chugai Pharmaceutical today revealed that it has filed a regulatory application with the Ministry of ...

Belgian pharma UCB today announced that the Phase III study investigating the safety and efficacy of adjunctive fenfluramine ...

US biopharma company Altimmune saw its share slump almost 55% to $3.48 yesterday, after it announced what it called ‘positive ...

US pharma major Merck & Co has secured a key endorsement for its newly approved respiratory syncytial virus (RSV) prevention ...

Rising use of innovative medicines and shifting spending patterns are reshaping the global pharmaceutical landscape, ...

US pharm giant Pfizer today announced positive top-line results from the Phase III BASIS study evaluating Hympavzi ...